Prognostic significance of neutrophil to lymphocyte ratio in patients with metastatic breast cancer on the background of eribulin therapy

Prognostic significance of neutrophil to lymphocyte ratio in patients with metastatic breast cancer on the background of eribulin therapy

Background. The neutrophil to lymphocyte ratio (NLR) is a prognostic marker in various carcinomas, including breast cancer. The NLR reflects the balance of systemic immunity and is associated with survival in patients with solid tumors.Aim. This study retrospectively evaluated the significance of th...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Zyuzyukina, V. A. Komissarova, N. O. Popova, V. E. Goldberg, R. A. Zukov
Format:	Article
Language:	Russian
Published:	ABV-press 2022-09-01
Series:	Опухоли женской репродуктивной системы
Subjects:	breast cancer chemotherapy eribulin neutrophil to lymphocyte ratio absolute lymphocyte count
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/969
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic value of neutrophil-lymphocyte ratio, absolute lymphocyte count, and thrombocyte-lymphocyte ratio in predicting the outcomes of tetralogy of fallot primary repair
by: Sisca Natalia Siagian, et al.
Published: (2025-06-01)

Eribulin in Metastatic Breast Cancer: Actual Clinical Practice
by: A. V. Sultanbaev, et al.
Published: (2023-04-01)

Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study
by: L. A. Tashireva, et al.
Published: (2022-01-01)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and prognosis after aneurysmal subarachnoid hemorrhage: a cohort study
by: Adilson Jose Manuel de Oliveira, et al.
Published: (2023-06-01)

The prognostic impact of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy
by: Magdalena Krakowska, et al.
Published: (2018-09-01)

Clinico-haematological profile in COVID-19 patients: an observational study at tertiary care center
by: Jayalaxmi Yadav Kallur, et al.
Published: (2021-09-01)

Relationship between Absolute Lymphocyte Count and Ascites in Patients with Liver Cirrhosis
by: Nathasya Rizkyana Riyadi, et al.
Published: (2024-01-01)

Preoperative anemia is associated with prolonged hospital stay and increased facility discharges after glioblastoma resection
by: Ahmad K. Almekkawi, et al.
Published: (2025-01-01)

10 years of success achieved by eribulin while treating HER2-negative mBC: from randomized studies to routine practice
by: I. V. Kolyadina
Published: (2021-10-01)

Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
by: V.Y. Tseluyko, et al.
Published: (2025-05-01)

Early lymphocyte recovery after allogeneic transplantation of hematopoietic stem cells in patients with haematological malignancies: a single-centre experience
by: Kameliya Kostadinova, et al.
Published: (2025-08-01)

Correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with prognosis in gastric cancer patients undergoing neoadjuvant chemotherapy: a meta-analysis
by: Shuang Yang, et al.
Published: (2025-07-01)

CLINICAL ECONOMIC ANALYSIS OF USING ERIBULIN (HALAVEN®) FOR TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER
by: S. L. Plavinsky, et al.
Published: (2016-02-01)

Ratios of neutrophils to lymphocytes and platelets to lymphocytes in ankylosing spondylitis with disease activity relationship
by: Shahla Taha Ahmad, et al.
Published: (2024-12-01)

Eribulin in Heavily Pre-Treated Metastatic Breast Cancer: A Case Series
by: Andini Kartikasari, et al.
Published: (2025-04-01)

The Predictive Value of Absolute Lymphocyte Count and T Cell Subpopulations for Sepsis Prognosis
by: Jia X, et al.
Published: (2024-11-01)

Lymphocyte levels in Crohn’s disease patients in clinical remission are significantly lower than those in healthy people
by: Asi He, et al.
Published: (2025-02-01)

The significance of the neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio in the aetiology of febrile seizures in children
by: Ewa Grzywna-Rozenek, et al.
Published: (2025-04-01)

Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in IgA Vasculitis
by: Kaoru Ikeno, et al.
Published: (2024-03-01)

Role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in oral cavity cancers
by: Akshat Malik, et al.
Published: (2019-01-01)

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review
by: Stefano Salciccia, et al.
Published: (2024-04-01)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Patients with Hepatocellular Carcinoma Receiving HAIC-Based Conversion Hepatectomy: A Dual-Center Retrospective Cohort Study
by: Li D, et al.
Published: (2025-07-01)

Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas
by: Jonathan Noujaim, et al.
Published: (2016-01-01)

Neutrophil and neutrophil-lymphocyte ratios as predictors of clinical characteristics in patients with Lymphangioleiomyomatosis
by: Lulu Yang, et al.
Published: (2025-06-01)

Research advances of neutrophil-to-lymphocyte ratio in kidney diseases
by: Liang Chun-mei, et al.
Published: (2022-01-01)

Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review
by: Herleeyana Meriyani, et al.
Published: (2025-02-01)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer
by: Sat Prasad Nepal, et al.
Published: (2023-04-01)

THE DIFFERENCE OF NEUTROPHIL LYMPHOCYTE RATIO (NLR) IN CONVENTIONAL AND ELECTRIC SMOKERS
by: Diah Ayu Siti Sarah, et al.
Published: (2020-05-01)

Difference of Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Non-Hodgkin and Hodgkin Lymphoma
by: Frenky Jones, et al.
Published: (2024-12-01)

Optimal Timing of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Early Predictors of Neurological Outcomes in Postcardiac Arrest Patients
by: Dongju Kim, et al.
Published: (2024-11-01)

Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio
by: Jing Yu, et al.
Published: (2024-12-01)

Possible Use of Absolute Lymphocyte Count as Surrogate for CD4+ Cells Count in Monitoring Response to Highly Active Antiretroviral Therapy in Sokoto.
by: Onuigwe, F.U., Alimi, R., Balarabe, I., Uko, E., Uchechukwu, N.J., Erhabor, O.
Published: (2016-07-01)

Correlation of Neutrophil-Lymphocyte Ratio with the Evidence of Stroke Haemorrhagic at Tertiary Hospitals
by: Made Wulan Utami Dewi, et al.
Published: (2023-11-01)

Diagnostic accuracy of neutrophil-to-lymphocyte ratio in type 2 diabetic nephropathy: a meta-analysis
by: Yan Wang, et al.
Published: (2025-07-01)

Research advances in relationship of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with chronic kidney diseases
by: HE Jia-yan, et al.
Published: (2019-01-01)

The Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Predicting Atrial Fibrillation and Its Comorbidities
by: Evelina Maria Gosav, et al.
Published: (2025-06-01)

The correlation of both neutrophil/lymphocyte and platelet/lymphocyte ratios with disease activity in ankylosing spondylitis patients
by: Ahmed Ibrahim Hammad, et al.
Published: (2025-06-01)

Cost-effectiveness analysis of eribulin versus dacarbazine in patients with advanced liposarcoma
by: Miaomiao Zhang, et al.
Published: (2025-01-01)

Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Correlation with Rheumatoid Arthritis Disease Activity
by: Noor Hasan Baiee, et al.
Published: (2025-01-01)

Is the Neutrophil-to-Lymphocyte Ratio a Predictive Factor of Pathological Complete Response in Egyptian Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
by: Naglaa F. Ebaid, et al.
Published: (2025-02-01)